Sheng F. Cai

机构：Memorial Sloan Kettering Cancer Center, Washington University in St. Louis, Kettering University · ORCID：0000-0002-2708-887X

发表论文 179 篇 · 总被引 3757 次 · h-index 25

代表论文

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AML (2025 · Journal of Clinical Oncology · 被引 45)
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia (2025 · Cell stem cell · 被引 26)
Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure (2025 · Blood Advances · 被引 9)
Advances in menin inhibition in acute myeloid leukemia (2025 · Trends in cancer · 被引 9)
Combination Strategies with Menin Inhibitors for Acute Leukemia (2025 · Blood Cancer Discovery · 被引 8)
Overcoming MEN1-mediated resistance with menin inhibitor switching in KMT2A-rearranged acute myeloid leukemia (2026 · Leukemia · 被引 6)